Journal of Infection in Developing Countries

Papers
(The H4-Index of Journal of Infection in Developing Countries is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
The practice of COVID-19 preventive measures in Palestine on the limits of vaccine provision: a population-based study84
Shifts in hospital-associated pathogens and prevalence trends of carbapenem-resistant Escherichia coli infections, 2021–202330
Use of qRT-PCR for SARS-CoV-2 sgRNA leader for the therapeutic plan: a preliminary report on 10 patients29
Identification of the first case of Penicillium marneffei infection in Shaanxi province by nanopore sequencing27
Mortality predictors on the day of healthcare-associated Acinetobacter baumanni bacteremia in intensive care unit25
Hematological profile among cutaneous leishmaniasis patients before and after treatment with sodium stibogluconate in Diyala, Iraq23
Sequels of COVID-19 in nephrology. Chronic kidney patients are more prone to hemodialysis need and mortality21
The controverted therapeutic efficacy of Allium sativum and Artemisia herba-alba extracts on Cryptosporidium-infected mice19
SARS-CoV-2 genetic diversity and variants of concern in Saudi Arabia19
Impact of vaccination on ICU admissions of hospitalized COVID-19 patients in a country with a heterologous vaccine policy18
Successful treatment of peritonitis caused by Acremonium species without catheter removal: Case report and literature review18
Social Network Strategy improves access to HIV testing and harm reduction programs for PWID and their partners in Kazakhstan18
Side effects of COVID-19 vaccines among Iranian healthcare workers: a retrospective cohort study17
Real-life outcomes of COVID-19 vaccination in kidney transplant patients: a single-center experience17
Optimized Case Finding of tuberculosis among key populations in Ukraine. A follow up study17
A study of anti-SARS-CoV-2 antibody positivity in Duhok City, Iraq16
0.20217680931091